Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03939897
Title Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 United States Details
UC Irvine Health Cancer Center-Newport Costa Mesa California 92627 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Siteman Cancer Center-South County Saint Louis Missouri 63129 United States Details
Siteman Cancer Center at Christian Hospital Saint Louis Missouri 63136 United States Details
Siteman Cancer Center at Saint Peters Hospital Saint Peters Missouri 63376 United States Details
Bellevue Hospital Center New York New York 10016 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016 United States Details
Wake Forest University at Clemmons Clemmons North Carolina 27012 United States Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field